When was MON VETO acquired by ARDIAN?

MON VETO was acquired by ARDIAN in 2023.

What was the revenue of MON VETO at the time of the deal?

The revenue of MON VETO at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of MON VETO during the acquisition?

MON VETO's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the MON VETO acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the MON VETO deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.ardian.com/fr/actualites-perspectives/communiques-de-presse/ardian-annonce-une-prise-de-participation-dans-le

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaMON VETO

06/2023

MON VETO acquired by ARDIAN

FRANCE Health Providers / Outpatient Care / Vet Clinics REV 100M - 200M EUR

Context

Ardian acquired a minority stake (approximately 20%) in Mon Veto through a primary capital increase. This "pure cash-in" operation was designed to strengthen the group's equity base without any cash-out for the founding veterinarians. The transaction supports Mon Veto's aggressive buy-and-build strategy in a rapidly consolidating European market. The partnership aims to accelerate the group's domestic expansion and facilitate its entry into highly fragmented international markets, such as Italy and Spain. The existing unitranche debt facility provided by Barings was maintained and extended to support future external growth, ensuring the group remains a top independent contender against large international corporate aggregators.

MON VETO, which reported an EBITDA margin of in 2022, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 2010, Mon Veto is the leading independent operator of veterinary clinics in France. The group manages a network of 231 clinics across France and Belgium, employing over 1,200 people, including 550 veterinarians. The company specializes in creating local geographic clusters to foster synergies between clinics and improve the quality of animal care through shared resources and training.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2022

2021

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
08/2023	BAIN CAPITAL	ESTIA HEALTH	AUSTRALIA	Nursing Homes
07/2023	MEDIAN KLINIKEN	HESTIA ALLIANCE	SPAIN	Clinics / Hospitals
06/2023	PARQUEST CAPITAL	IMANEO	FRANCE	Radiology
06/2023	Levine Leichtman Capital Partners	SEV Laser	UNITED STATES	Aesthetic & Cosmetic Clinics
11/2022	RADNET	HEART & LUNG IMAGING	UNITED KINGDOM	Radiology
10/2022	CBPE CAPITAL	VEINCENTRE	UNITED KINGDOM	Aesthetic & Cosmetic Clinics
09/2022	EURAZEO	IMAPOLE	FRANCE	Radiology
09/2022	ORADIANSE	REVEL	FRANCE	Radiology
08/2022	FREEMAN SPOGLI	EVERVET PARTNERS	UNITED STATES	Vet Clinics
07/2022	INFRAVIA CAPITAL	UNIVET	FRANCE	Vet Clinics

REFERENCES

Revenue range: 100M - 200M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MON VETO by ARDIAN are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: ardian